Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03273842 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
A Phase 1 study of Healthy Volunteers, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 422
- Enrollment target
- 4
- Study locations
NCT03273842 is a Phase 1 study of Healthy Volunteers that has completed, run by Pfizer. The registered enrollment target is 422 participants, below the 480-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (12% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT03273842, a Phase 1 study of Healthy Volunteers, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 422 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study compares the immune response to the proposed biosimilar PF-06881894 and the US-approved Neulasta reference product. Subjects will receive 2 subcutaneous injections (6 milligrams \[mg\]) either 1 of the 2 study drugs. Subjects will receive the first dose on Day 1 of Period 1 and the second dose on Day 1 of Period 2. Pre-dose and serial post-dose assessments of immunogenicity will be conducted each of the two treatment periods. In addition, safety assessments will be conducted throughout the study.
Conditions Studied
Interventions
- BIOLOGICAL PF-06881894
- BIOLOGICAL US-approved Neulasta
Study Locations (4)
Florida
- Seaview A Quotient Clinical Business - Coral Gables
- Quotient Sciences- Jacksonville, LLC - Jacksonville
- Seaview A Quotient Clinical Business - Miami
Kansas
- Vince & Associates Clinical Research Inc. - Overland Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 422 participants |
| Start Date | 2017-10-27 |
| Est. Completion | 2018-07-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03273842
The ClinicalTrials.gov registry entry for NCT03273842 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 422 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 480-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (12% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Volunteers appearing as the primary indexed condition, and to 2 interventions - of which PF-06881894 is the first listed.
NCT03273842 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Florida, Kansas.
Frequently Asked Questions
What is clinical trial NCT03273842 about?
NCT03273842 is a clinical study titled "A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers". This study compares the immune response to the proposed biosimilar PF-06881894 and the US-approved Neulasta reference product. Subjects will receive 2 subcutaneous injections (6 milligrams \[mg\]) either 1 of the 2 study drugs. Subjects will receive the first dose on Day 1 of Period 1 and the second...
What is the current status of trial NCT03273842?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 422 participants. The study started on 2017-10-27. Estimated completion is 2018-07-25.
What conditions does trial NCT03273842 study?
This clinical trial studies the following conditions: Healthy Volunteers.
What interventions are being tested in trial NCT03273842?
The interventions under investigation include: PF-06881894 (BIOLOGICAL), US-approved Neulasta (BIOLOGICAL).
Who is sponsoring clinical trial NCT03273842?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03273842 being conducted?
This trial has 4 study locations across Florida, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult Participants
RECRUITING · Phase 1
-
A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.
RECRUITING · Phase 1
-
Classroom Break, Cognition, and Fitness in Elementary School Children
RECRUITING · Phase 1
-
A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adult Participants
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.